COVID-19 vaccine should be able to give protection for 8-10 months: AIIMS Director

Says no major side-effect of the vaccine has been recorded

COVID-19 vaccine should be able to give protection for 8-10 months: AIIMS Director

Photo for representational purpose only. PTI file

New Delhi, March 20

The COVID-19 vaccine should be able to give good protection from the infection for eight to ten months, AIIMS director Randeep Guleria said on Saturday.

He also said that no major side-effect of the vaccine has been recorded.

“The COVID-19 vaccine should be able to give good protection from the infection for eight to ten months and maybe, even more,” Guleria said at an event organised by the IPS (Central) Association.

He said the biggest reason for the surge in cases is that people feel the pandemic is over and they are not following COVID-appropriate behaviour.

“There are multiple reasons for the surge, but the main reason is that there is change in people’s attitude and they feel coronavirus is over. People should still restrict non-essential travel for some more time,” the official asserted.

NITI Aayog member (Health) V K Paul said the chain of transmission has to be stopped and for that vaccine is one tool but another is containment and surveillance strategy.

“Not following COVID-19 behaviour and laxity is major reason for the surge,” he said.

Responding to a question on vaccinating more people, Paul said the issue is vaccines are limited and that is why, prioritisation has been done.

“If we had unlimited supply, we would open the vaccination for everyone. That is the reason, not everyone, is getting vaccinated. Most countries in the world are not able to go beyond priority group because of this reason,” he said.

The NITI Aayog member also said that the highest mortality was seen among people with co-morbidities and older age groups.

“These people must not delay taking the vaccine. So the message is that they need it more than others. That is the reason they have been prioritised for getting the COVID-19 vaccine,” he said.

Talking about the effectiveness of the available COVID-19 vaccines, Covaxin and Covishield, Guleria said, “If we look at the two vaccines, they produce equal antibodies and are very robust. We should take the vaccine available to us because both are equally effective in terms of efficacy and long-term protection.”

Over four crore people in the country have been vaccinated against the virus till now. Under the current phase of the inoculation drive, people above 60 years of age and those in the 45-59 years age bracket with co-morbidities, are being vaccinated. PTI

Top Stories

Sputnik vaccine to cost Rs 995 per shot

Sputnik vaccine to cost Rs 995 per shot

First dose of vaccine was administered in Hyderabad on Frida...

Recoveries outnumber daily COVID-19 cases, over two crore recovered so far

Recoveries outnumber daily COVID-19 cases, over two crore recovered so far

More than 20 lakh vaccination doses were administered in a s...

Centre says it will provide assistance to all companies willing to manufacture vaccines

Centre says it will provide assistance to all companies willing to manufacture vaccines

Bharat Biotech is also ramping up its capacity and has alrea...

Five children among six who drown near Ludhiana village

Five children among six who drown near Ludhiana village

Punjab CM mourns deaths; announces Rs 50,000 each for the fa...

Cities

View All